Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P O'Callaghan

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Metabolism: Clinical and Experimental|September 19, 2006
The pharmacology of wakefulnessDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|February 5, 2017
New horizons for focused ultrasound (FUS) - therapeutic applications in neurodegenerative diseasesDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|September 15, 2010
Spinal glia and chronic painJames P O'Callaghan, Diane B Miller
Environmental Research|April 23, 2003
Elevated environmental temperature and methamphetamine neurotoxicityDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|September 23, 2008
Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?Diane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|December 17, 2014
Biomarkers of Parkinson's disease: present and futureDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|October 16, 2019
Neuroinflammation disorders exacerbated by environmental stressorsJames P O'Callaghan, Diane B Miller
Journal of Neurochemistry|January 13, 2006
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alphaKrishnan Sriram, Diane B Miller, James P O'Callaghan
Annals of the New York Academy of Sciences|November 11, 2008
Defining "neuroinflammation"James P O'Callaghan, Krishnan Sriram, Diane B Miller
Neurotoxicology|November 16, 2007
Autoantibodies to neurotypic and gliotypic proteins as biomarkers of neurotoxicity: assessment of trimethyltin (TMT)Hassan A N El-Fawal, James P O'Callaghan
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Metabolism: Clinical and Experimental|September 19, 2006
The pharmacology of wakefulnessDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|February 5, 2017
New horizons for focused ultrasound (FUS) - therapeutic applications in neurodegenerative diseasesDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|September 15, 2010
Spinal glia and chronic painJames P O'Callaghan, Diane B Miller
Environmental Research|April 23, 2003
Elevated environmental temperature and methamphetamine neurotoxicityDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|September 23, 2008
Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?Diane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|December 17, 2014
Biomarkers of Parkinson's disease: present and futureDiane B Miller, James P O'Callaghan
Metabolism: Clinical and Experimental|October 16, 2019
Neuroinflammation disorders exacerbated by environmental stressorsJames P O'Callaghan, Diane B Miller
Journal of Neurochemistry|January 13, 2006
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alphaKrishnan Sriram, Diane B Miller, James P O'Callaghan
Annals of the New York Academy of Sciences|November 11, 2008
Defining "neuroinflammation"James P O'Callaghan, Krishnan Sriram, Diane B Miller
Neurotoxicology|November 16, 2007
Autoantibodies to neurotypic and gliotypic proteins as biomarkers of neurotoxicity: assessment of trimethyltin (TMT)Hassan A N El-Fawal, James P O'Callaghan
Pageof 11